Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $369,100.61 mil
Piotroski score: 9
PE Ratio: 87.4169
EPS (TTM): 2.3828
Revenue (TTM): $34.44 M
Dividend Yield: 3.3202187889838%
ROE: 95.59%
Latest News
-
Why AbbVie Is a No-Brainer Stock to Buy on the Dip
Thu, Apr 16, 2026 8:01 PM
-
Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031
Thu, Apr 16, 2026 3:24 PM
-
1 Value Stock Worth Your Attention and 2 That Underwhelm
Thu, Apr 16, 2026 1:46 PM
-
Wall Street Lunch: Europe Stares At Jet Fuel Crunch Amid Hormuz Disruption
Thu, Apr 16, 2026 12:58 PM
-
FDA Takes Step Forward on Testosterone Therapy for Men
Thu, Apr 16, 2026 11:37 AM
-
Evercore ISI Tweaks AbbVie (ABBV) Estimates, Lowers Price Target Marginally
Wed, Apr 15, 2026 5:10 PM
-
Johnson & Johnson Reported Above-Peer Topline Growth in Q1, BofA Says
Wed, Apr 15, 2026 4:06 PM
-
3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market
Wed, Apr 15, 2026 3:35 PM
-
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Wed, Apr 15, 2026 8:16 AM
-
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Tue, Apr 14, 2026 9:45 PM
Key Financials
Financial data not available
